Cargando…

Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy

Convalescent plasma has been extensively tested during the COVID-19 pandemic as a transfusion product. Similarly, monoclonal antibodies have been largely administered either intravenously or intramuscularly. Nevertheless, when used against a respiratory pathogen, respiratory delivery is preferable t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Focosi, Daniele, Maggi, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561570/ https://www.ncbi.nlm.nih.gov/pubmed/37799070 http://dx.doi.org/10.1080/21645515.2023.2260040

Ejemplares similares

Recombination in Coronaviruses, with a Focus on SARS-CoV-2
por: Focosi, Daniele, et al.
Publicado: (2022)

SARS-CoV-2: Advances in Serological Methods and the Understanding of Antibody Escape
por: Focosi, Daniele, et al.
Publicado: (2023)

How SARS-CoV-2 Big Data Are Challenging Viral Taxonomy Rules
por: Focosi, Daniele, et al.
Publicado: (2023)

Second-Generation SARS-CoV-2 Recombinants: Lessons from Other Viruses
por: Focosi, Daniele, et al.
Publicado: (2023)

Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
por: Focosi, Daniele, et al.
Publicado: (2022)

SARS-CoV-2 recombinant XN, Italy
por: Novazzi, Federica, et al.
Publicado: (2022)

SARS-CoV-2 BA.2.86 (“Pirola”): Is it Pi or Just Another Omicron Sublineage?
por: Focosi, Daniele, et al.
Publicado: (2023)

The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19
por: Focosi, Daniele, et al.
Publicado: (2021)

Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic
por: Focosi, Daniele, et al.
Publicado: (2022)

A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV)
por: Noor, Rashed
Publicado: (2021)

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
por: Focosi, Daniele, et al.
Publicado: (2021)

Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy
por: Novazzi, Federica, et al.
Publicado: (2022)

Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
por: Tuccori, Marco, et al.
Publicado: (2020)

Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients
por: Azzi, Lorenzo, et al.
Publicado: (2021)

Analysis of SARS-CoV-2 sublineages reported from local cases in mainland China (September 2022-January 2023) and surveillance of outbound passengers.
por: Focosi, Daniele, et al.
Publicado: (2023)

Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Zhang, Chao, et al.
Publicado: (2020)

SARS-CoV-2 Mutations and their Viral Variants
por: Cosar, Begum, et al.
Publicado: (2022)

Monoclonal antibody therapies against SARS-CoV-2
por: Focosi, Daniele, et al.
Publicado: (2022)

Antibodies and SARS-CoV-2: New Data on Diagnostics and Therapeutics
por: Focosi, Daniele, et al.
Publicado: (2022)

SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply
por: Franchini, Massimo, et al.
Publicado: (2023)

SARS-CoV-2 (COVID-19) and the Endocrine System
por: Lundholm, Michelle D, et al.
Publicado: (2020)

Thyroiditis and SARS-CoV-2 pandemic: a review
por: Caron, Philippe
Publicado: (2021)

Therapeutic antibodies under development for SARS‐CoV‐2
por: Ma, Zetong, et al.
Publicado: (2021)

Impact of SARS-CoV-2 infection on liver disease
por: Salgüero Fernández, Sergio, et al.
Publicado: (2022)

Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19
por: Karthik, Kumaragurubaran, et al.
Publicado: (2020)

Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases
por: Focosi, Daniele, et al.
Publicado: (2022)

Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
por: Mudgal, Rajat, et al.
Publicado: (2020)

Laboratory diagnosis of SARS-CoV-2: available approaches and limitations
por: Abduljalil, J.M.
Publicado: (2020)

The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection
por: Huizinga, Gabrielle P, et al.
Publicado: (2020)

Endocrine Significance of SARS-CoV-2’s Reliance on ACE2
por: Lazartigues, Eric, et al.
Publicado: (2020)

Natural Immunomodulators Treat the Cytokine Storm in SARS-CoV-2
por: Abbas, Heba Salah, et al.
Publicado: (2023)

The role of environmental factors to transmission of SARS-CoV-2 (COVID-19)
por: Eslami, Hadi, et al.
Publicado: (2020)

Photonics enabled intelligence system to identify SARS-CoV 2 mutations
por: Taha, Bakr Ahmed, et al.
Publicado: (2022)

Could SARS‐CoV‐2 infection affect male fertility and sexuality?
por: delli Muti, Nicola, et al.
Publicado: (2022)

Electrochemical biosensors for the detection of SARS-CoV-2 pathogen and protein biomarkers
por: Zhang, Yintang, et al.
Publicado: (2022)

SARS-CoV-2 Burden in Wastewater and its Elimination Using Disinfection
por: Koirala, Prashanna, et al.
Publicado: (2023)

Facing SARS-CoV-2 outbreak in immunotherapy era
por: Citarella, Fabrizio, et al.
Publicado: (2020)

Cross-disciplinary approaches to assist with nucleic acid testing for SARS-CoV-2
por: Yang, Shujuan, et al.
Publicado: (2021)

Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism
por: Ahmad, Firdos, et al.
Publicado: (2022)

An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies
por: Spicuzza, Lucia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ul6oi010eavb289tht089uirj1